A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Recruiting
Phase 4
Interventional Study
COVID-19 Vaccines
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 200 (estimated)
- Sponsor
- BioNTech SE · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to 64 years of age.
This study is seeking participants who:
* are medically stable
* have not had a recent COVID-19 infection
* have not had a recent vaccination
* do not have medical conditions that increase their risk of complications from COVID-19
All participants …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria
\- Healthy participants 18 through 64 years of age who do not have medical conditions that put them at a higher risk for severe COVID-19.
Key Exclusion Criteria
* Participants who tested positive for COVID-19 within 6 months (180 days) prior to Visit 1
* Participants who ha…
Contacts